opioid growth factor

Known as: OGF 
A substance that relieves pain and is being studied in the treatment of some types of cancer. Opioid growth factors bind to cells in the body… (More)

Topic mentions per year

Topic mentions per year

1977-2017
051019772017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Naltrexone (NTX) is an opioid antagonist that inhibits or accelerates cell proliferation in vivo when utilized in a low (LDN) or… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide, with a mortality rate approximating its… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Naltrexone, an opioid antagonist, has been shown to modulate expression of experimental autoimmune encephalomyelitis (EAE), an… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Ovarian cancer is the leading cause of death from gynecological malignancies. Understanding the biology of these tumors, as well… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
The opioid growth factor (OGF) regulates cell proliferation of human cancer cells through the cyclin-dependent kinase inhibitory… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2000
2000
OBJECTIVE Induced angiogenesis has recently been attempted as a therapeutic modality in patients with occlusive arterial… (More)
Is this relevant?
2000
2000
The native opioid growth factor (OGF), [Met5]-enkephalin, is a tonic inhibitory peptide that modulates cell proliferation and… (More)
Is this relevant?
1999
1999
Human neuroblastoma is one of the most common solid tumors in infants and children and represents about 10% of all childhood… (More)
Is this relevant?
1999
1999
In addition to neurotransmission, the native opioid peptide, [Met5]enkephalin, is a tonically active inhibitory growth molecule… (More)
Is this relevant?
1999
1999
Pancreatic adenocarcinoma is a fatal malignancy that ranks as the fourth most common cause of cancer-related mortality in the… (More)
Is this relevant?